Visual Studio Code 1.129 adds a dedicated process for running AI agent sessions and an experimental docked editor for reviewing agent-generated changes.

A new class of content creators is emerging in the era of vibe coding. Danger Testing raised $2.6 million to capitalize.

GitHub Copilot security review launched in the desktop app July 14, giving all subscribers — Free tier included — AI-driven ...

Some of us were chatting the other day and one of our group remarked, "I have trouble thinking the economy is suffering in Jefferson City. The restaurants are always full. Missouri Boulevard with all ...

An error has occurred. Please try again. With a The Portland Press Herald subscription, you can gift 5 articles each month. It looks like you do not have any active ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. When Chuck Schumer emerged from a Capitol Hill meeting with Graham ...

A security researcher has released exploit code for a Visual Studio Code (VS Code) zero-day vulnerability that allows attackers to steal GitHub authentication tokens by tricking users into clicking a ...

The controversy over vibe coding reached a new high this week after a developer added hidden instructions to his open source Java testing app to sabotage projects performed by AI coding agents. The ...

The first Minecraft 26.2 pre-release is here for Java Edition, but there's some bad news if you've been taking advantage of the sandbox game's new peer-to-peer multiplayer, which was implemented in a ...

As tools like Claude Code get better, more and more developers are happy to hand off coding tasks to them. The way software gets built has changed for good. The vibes were strong at Code with Claude, ...

The UIL Texas Class 6A high school state track meet was held Saturday at Mike A. Myers Field in Austin. Southlake Carroll senior Caden Leonard entered the state meet looking to win three consecutive ...

Does prostate cancer screening save lives? The Cochrane, an influential group renowned for its gold-standard medical reviews, has previously addressed that question twice, and twice the answer was ‘no ...